Researchers at Northeastern University have shown how a protein called TMEM16A opens pores in human cell membranes by coupling calcium ions with a membrane lipid through an electrostatic network centered on a single structural helix. The findings, published in the Proceedings of the National Academy of Sciences, answer a long-standing question about how cells regulate the flow of chloride ions, a process tied to secretion, muscle contraction, and a range of diseases. By combining computational modeling with live-cell microscopy, the team captured ion movement across the membrane in real time, revealing a cooperative gating mechanism that had eluded scientists for nearly two decades.
How TMEM16A Forces Open a Pore
TMEM16A was first identified in 2008 as a calcium-activated chloride channel component, confirmed independently by separate research groups who also linked the protein to calcium-dependent chloride channel activity with broad physiological relevance to secretion and excitability. But knowing what the channel does and knowing how it opens are different problems. Scientists understood that both intracellular calcium and a membrane lipid called PIP2 were required for the channel to function, yet the precise mechanism connecting those two inputs remained unclear. Earlier structural and computational work had identified PIP2 binding sites on the protein, but the cooperative relationship between calcium and PIP2 was not resolved.
The new PNAS study fills that gap. Lead researcher Sandip Bidkar and colleagues combined computation with a custom evanescent-illumination microscope on live cells to observe ion movement across the membrane with millisecond resolution. Their results, also summarized in a recent news report, show that TMEM16A opening is cooperatively gated by intracellular calcium and membrane lipid PIP2 through an allosterically coupled electrostatic network centered on the protein’s alpha-4 helix, a finding supported by molecular dynamics simulations. In practical terms, the alpha-4 helix acts as a relay: calcium binding on one side of the protein communicates with PIP2 engagement on another, and only when both signals converge does the channel open to allow chloride ions through. This dual requirement explains a well-documented laboratory phenomenon called “rundown,” in which the channel gradually loses activity in excised membrane patches as PIP2 depletes. Earlier work had documented that calcium and PIP2 jointly affect TMEM16A function, including rundown behavior, but could not explain the structural coupling that makes both signals necessary.
TMEM16A in Physiology and Disease
Chloride channels like TMEM16A are embedded in a broader landscape of ion transporters that keep cells electrically and chemically balanced. In epithelial tissues, TMEM16A helps drive chloride and fluid secretion, contributing to processes such as airway hydration and gastrointestinal motility. In smooth muscle, its calcium-activated conductance shapes membrane potential and contractility, linking microscopic pore opening events to macroscopic phenomena like blood vessel tone and peristalsis. Because these functions are tightly tuned, even subtle changes in channel gating can ripple outward into organ-level physiology. The new work on the alpha-4 helix provides a mechanistic basis for understanding how shifts in intracellular calcium or membrane lipid composition could selectively modulate TMEM16A activity without permanently damaging the membrane.
Dysregulation of chloride channels has been implicated in conditions ranging from hypertension to certain cancers, and TMEM16A itself has drawn attention as a potential therapeutic target. Overexpression of the channel has been reported in several tumor types, where enhanced chloride flux may support cell proliferation and migration. At the same time, impaired activation in secretory epithelia could contribute to mucus stasis and chronic infection. By clarifying how calcium and PIP2 jointly gate TMEM16A, the Northeastern team’s findings may inform the design of small molecules that either stabilize the closed state or enhance opening under specific conditions. A recent structural analysis of TMEM16A variants has already begun to map how disease-linked mutations alter channel behavior, with mutational scanning pointing to residues near the alpha-4 helix as critical determinants of gating. Together, these lines of evidence suggest that the electrostatic network uncovered in the new study is not just a biophysical curiosity but a plausible intervention point for future drugs.
Why Cells Need Controlled Holes
The idea of a protein punching holes in a cell membrane sounds destructive, but controlled pore formation is one of the most important tools in biology. Cell membranes mediate functions ranging from intercellular recognition and cell-cell communication to the selective transport of ions that keeps every tissue in the body electrically balanced. Membrane organization has also been connected with a large number of human diseases, making any advance in understanding how pores form and close directly relevant to drug development. Proteins such as ion channels, transporters, and receptors all exploit the same basic principle: a hydrophobic lipid bilayer is normally impermeable to charged molecules, so proteins must transiently create aqueous pathways that are tightly regulated in space and time.
TMEM16A’s chloride channel sits at one end of a spectrum of pore-forming proteins. At the other end are molecules designed to kill. The PRF1 gene, for example, encodes a protein called perforin that is found in immune cells known as lymphocytes; according to genetic reference data, PRF1 provides instructions for making perforin, which is essential for cytotoxic lymphocyte function and immune regulation. Perforin is a 67-kDa multidomain protein that oligomerizes to form a pore on the target cell membrane, and that pore formation is the key step to its cytotoxic function. The groups of Henkart, Okumura, and Podack originally isolated this monomeric granule protein, observed that it assembled into membrane-spanning pores, and named it perforin, highlighting its role in “perforating” target cells. Unlike TMEM16A, which passes small chloride ions, perforin forms large, nonselective pores that allow cytotoxic enzymes to flood into the cell.
Pore-Forming Proteins That Trigger Inflammation
Perforin plays a central role in immune defense against pathogens and in the removal of cancer cells, delivering toxic enzymes called granzymes into targets at immune synapses formed between cytotoxic T lymphocytes and the cells they attack. Reviews of cytotoxic lymphocyte biology emphasize that perforins play crucial roles in recognizing and eliminating virus-infected and malignant cells, leading to the initiation of apoptosis in the targets. The calcium-dependent perforin egress toward target cells is ensued by PI3K signaling, and the protein forms transmembrane pores using its membrane-spanning MACPF domain. What links perforin to TMEM16A is the shared dependence on calcium as a gating signal, though the downstream consequences differ sharply: one regulates ion balance, the other triggers cell death. In both cases, however, the cell must convert a diffuse chemical signal (rising intracellular calcium) into a precise structural rearrangement that opens a pore at exactly the right place and time.
Beyond perforin, another family of pore-forming proteins has drawn intense research attention. Gasdermins are a family of homologous pore-forming proteins consisting of six genes (GSDMA through E and DFNB59) that cause pyroptosis, an inflammatory form of cell death. When a gasdermin is cleaved by inflammatory caspases or other proteases, its released N-terminal domain forms pore-forming oligomers that insert into the cell membrane, leading to pyroptosis activation. Those oligomers grow into large and stable ring-like structures, creating transmembrane pores that ultimately cause cell lysis and the release of pro-inflammatory contents such as IL-1β. In contrast to the relatively small and tightly regulated pores of TMEM16A, gasdermin pores act as molecular escape hatches for danger signals, ensuring that infection or damage in one cell can rapidly alert the surrounding tissue and the immune system at large.
Connecting Molecular Gating to Therapeutic Possibilities
Together, TMEM16A, perforin, and gasdermins illustrate how cells reuse a simple architectural solution, a hole in the membrane, for radically different purposes. The Northeastern study adds a crucial piece to this picture by revealing how an electrostatic network around TMEM16A’s alpha-4 helix couples calcium and PIP2 binding to pore opening. That level of mechanistic detail is not just of academic interest. It provides a blueprint for rationally modulating channel activity. A drug that stabilizes the alpha-4 helix in its closed conformation, for example, could dampen chloride secretion in tissues where TMEM16A is overactive, while a compound that enhances its responsiveness to physiological calcium spikes might help restore secretion in diseases marked by impaired channel function. Because the gating mechanism relies on electrostatic interactions, it may be particularly amenable to small molecules designed to alter local charge distributions or to lipids that compete with PIP2 at key binding sites.
At the same time, understanding the parallels and contrasts between TMEM16A and more destructive pore-forming proteins may inspire new strategies for immunotherapy and anti-inflammatory treatment. Perforin and gasdermin pores are powerful but potentially dangerous tools. Too little activity can leave the body vulnerable to infection and cancer, while excessive or misdirected pore formation can cause immunopathology and chronic inflammation. Insights into how calcium signals and membrane lipids coordinate TMEM16A gating could inform efforts to fine-tune perforin release or gasdermin activation, perhaps by targeting upstream signaling pathways or shared membrane microdomains. As researchers continue to dissect the structural logic of pore formation across these protein families, the line between basic membrane biophysics and clinical application is likely to blur, turning what once seemed like mysterious holes in the cell surface into precisely controllable therapeutic targets.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
